CDC Notice of Intent to Sole Source for Inhalation Support / TSI MOUDI-II Instrument

The Centers for Disease Control and Prevention (CDC) intends to award a sole-source purchase order to TSI Incorporated for a Micro Orifice Uniform-Deposit Impactor (MOUDI-II) instrument to support inhalation research. This procurement, identified under solicitation number 75D301-26-Q-98063, is being conducted because TSI Incorporated is the only manufacturer of an instrument capable of meeting the specific wide range of size classification and uniform sample deposition required for the agency's research objectives. The performance of these services and the delivery of the equipment will take place in Morgantown, West Virginia.

This requirement is classified under NAICS 334516 Analytical Laboratory Instrument Manufacturing and PSC 6640 LABORATORY EQUIPMENT AND SUPPLIES, with an SBA (SBA) set-aside designation. The government has provided two attachments related to this notice: a statement of work and a technical specification sheet for the MOUDI-II impactors. Although the agency intends to move forward with a sole-source award, any party that believes they can perform this requirement may submit a capability statement for consideration by the government.

All capability statements and inquiries must be submitted via email to Aminah A. Gary by the response deadline of June 25, 2026. Information received as a result of this notice will be evaluated solely for the purpose of determining whether to conduct a competitive procurement. The government maintains full discretion regarding the decision to compete this contract based on the responses received.